These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 36377848)
21. Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential. Seyedabadi M; Ghahremani MH; Albert PR Pharmacol Ther; 2019 Aug; 200():148-178. PubMed ID: 31075355 [TBL] [Abstract][Full Text] [Related]
23. Mu opioid receptor-effector coupling and trafficking in dorsal root ganglia neurons. Walwyn WM; Wei W; Xie CW; Chiu K; Kieffer BL; Evans CJ; Maidment NT Neuroscience; 2006 Oct; 142(2):493-503. PubMed ID: 16887280 [TBL] [Abstract][Full Text] [Related]
24. Snapshot of the cannabinoid receptor 1-arrestin complex unravels the biased signaling mechanism. Liao YY; Zhang H; Shen Q; Cai C; Ding Y; Shen DD; Guo J; Qin J; Dong Y; Zhang Y; Li XM Cell; 2023 Dec; 186(26):5784-5797.e17. PubMed ID: 38101408 [TBL] [Abstract][Full Text] [Related]
25. G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR. Miller WE; Houtz DA; Nelson CD; Kolattukudy PE; Lefkowitz RJ J Biol Chem; 2003 Jun; 278(24):21663-71. PubMed ID: 12668664 [TBL] [Abstract][Full Text] [Related]
26. Structure-Guided Design of Partial Agonists at an Opioid Receptor. Che T; Varga B; Bernhard SM; El Daibani A; Zaidi S; Lam J; Aguilar J; Appourchaux K; Nazarova A; Kouvelis A; Eans S; Margolis E; Fay J; Pradhan A; Katritch V; McLaughlin J; Majumdar S Res Sq; 2024 Jul; ():. PubMed ID: 39070616 [TBL] [Abstract][Full Text] [Related]
27. Angiotensin II inhibits DDAH1-nNOS signaling via AT1R and μOR dimerization to modulate blood pressure control in the central nervous system. Sun GC; Wong TY; Chen HH; Ho CY; Yeh TC; Ho WY; Tseng CJ; Cheng PW Clin Sci (Lond); 2019 Dec; 133(23):2401-2413. PubMed ID: 31755934 [TBL] [Abstract][Full Text] [Related]
28. ClickArr: a novel, high-throughput assay for evaluating β-arrestin isoform recruitment. French AR; Meqbil YJ; van Rijn RM Front Pharmacol; 2023; 14():1295518. PubMed ID: 38027002 [No Abstract] [Full Text] [Related]
29. Structural mechanism of GPCR-arrestin interaction: recent breakthroughs. Park JY; Lee SY; Kim HR; Seo MD; Chung KY Arch Pharm Res; 2016 Mar; 39(3):293-301. PubMed ID: 26825061 [TBL] [Abstract][Full Text] [Related]
30. The G protein-first activation mechanism of opioid receptors by Gi protein and agonists. Mafi A; Kim SK; Goddard WA QRB Discov; 2021; 2():e9. PubMed ID: 37529677 [TBL] [Abstract][Full Text] [Related]
31. Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions. Blaine AT; Miao Y; Yuan J; Palant S; Liu RJ; Zhang ZY; van Rijn RM Front Pharmacol; 2022; 13():914651. PubMed ID: 36059958 [TBL] [Abstract][Full Text] [Related]
32. Residues W320 and Y328 within the binding site of the μ-opioid receptor influence opiate ligand bias. Hothersall JD; Torella R; Humphreys S; Hooley M; Brown A; McMurray G; Nickolls SA Neuropharmacology; 2017 May; 118():46-58. PubMed ID: 28283391 [TBL] [Abstract][Full Text] [Related]